Maryam I. Azeem

Also affiliated with Virginia Commonwealth University, Winship Cancer Institute

MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “Clinical response and pathway-specific correlates following TIGIT–LAG3 blockade in myeloma: the MyCheckpoint randomized clinical trial”.

Clinical response and pathway-specific correlates following TIGIT–LAG3 blockade in myeloma: the MyCheckpoint randomized clinical trial

Nature Cancer(2024)10.1038/s43018-024-00818-w

N/A

0.727DataRank · unranked

20 citations

Alexander M. Lesokhin, Barry Paul, Jonathan L. Kaufman, Matthew J. Pianko, Noa Biran +9 more

Impaired SARS-CoV-2 Variant Neutralization and CD8+ T-cell Responses Following 3 Doses of mRNA Vaccines in Myeloma: Correlation with Breakthrough Infections

Blood Cancer Discovery(2022)10.1158/2643-3230.bcd-22-0173

N/A

0DataRank · unranked

33 citations

Ajay K. Nooka, Uma Shanmugasundaram, Narayanaiah Cheedarla, Sayalee Potdar, Renee Julia Manalo +23 more

Regulation of antigen-specific T cell infiltration and spatial architecture in multiple myeloma and premalignancy

Journal of Clinical Investigation(2023)10.1172/jci167629

N/A

0DataRank · unranked

47 citations

Nancy Villa, David L. Jaye, Ajay K. Nooka, Alyssa Duffy, Samuel S. McCachren +19 more

Data from Impaired SARS-CoV-2 Variant Neutralization and CD8+ T-cell Responses Following 3 Doses of mRNA Vaccines in Myeloma: Correlation with Breakthrough Infections

(2023)10.1158/2643-3230.c.6551220

N/A

0DataRank · unranked

0 citations

Ajay K. Nooka, Uma Shanmugasundaram, Narayanaiah Cheedarla, Sayalee Potdar, Renee Julia Manalo +23 more

Divergence of variant binding/neutralizing antibodies following SARS-CoV-2 booster vaccines in myeloma: Impact of hybrid immunity

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.08.17.553767

N/A

0DataRank · unranked

0 citations

Kelly E. Manning, Maryam I. Azeem, Ajay K. Nooka, Madison Ellis, Renee Julia Manalo +10 more

Divergence of variant binding/neutralizing antibodies following SARS-CoV-2 booster vaccines in myeloma: Impact of hybrid immunity

Research Square(2023)10.21203/rs.3.rs-3293339/v1

N/A

0DataRank · unranked

0 citations

Alberto Moreno, Kelly E. Manning, Maryam I. Azeem, Ajay K. Nooka, Madison Ellis +10 more

Divergence of variant antibodies following SARS-CoV-2 booster vaccines in myeloma and impact of hybrid immunity

npj Vaccines(2024)10.1038/s41541-024-00999-6

N/A

0DataRank · unranked

2 citations

Kelly E. Manning, Maryam I. Azeem, Ajay K. Nooka, Madison Ellis, Renee Julia Manalo +10 more

Early CD4+ T cell proliferation and chronic T cell engagement impact myeloma outcomes following T cell engager therapy

Journal of Clinical Investigation(2025)10.1172/jci192927

N/A

0DataRank · unranked

9 citations

Anshika Goenka, Maryam I. Azeem, Azmain Taz, Sayalee Potdar, Sara A. Scott +10 more

Determinants of Neutralizing Antibody Response After SARS CoV-2 Vaccination in Patients With Myeloma

Journal of Clinical Oncology(2022)10.1200/jco.21.02257

N/A

0DataRank · unranked

49 citations

Uma Shanmugasundaram, Narayanaiah Cheedarla, Hans Verkerke, Venkata Viswanadh Edara, Rajesh M. Valanparambil +16 more

Immune-aging at diagnosis determines T-cell recovery in childhood leukemia survivors

npj Aging(2025)10.1038/s41514-025-00233-0

N/A

0DataRank · unranked

0 citations

Sharon M. Castellino, Shivani Kapadia, Maryam I. Azeem, Ava Horvat, Taylor Lawrence +3 more